Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

February 1, 2009

Primary Completion Date

May 3, 2012

Study Completion Date

May 3, 2012

Conditions
CancerCarcinomaCastrate-Resistant Prostate CancerProstate CancerTumors
Interventions
DRUG

Denosumab

60 mg SC of Denosumab will be administered on study day 1, month 6, month 12, and month 18

Trial Locations (74)

1036

Research Site, Budapest

1204

Research Site, Budapest

4400

Research Site, Nyíregyháza

8230

Research Site, Balatonfüred

9023

Research Site, Győr

11530

Research Site, Garden City

11706

Research Site, Bay Shore

12208

Research Site, Albany

12601

Research Site, Poughkeepsie

14140

Research Site, Mexico City

17604

Research Site, Lancaster

20770

Research Site, Greenbelt

24153

Research Site, Salem

29572

Research Site, Myrtle Beach

33520

Research Site, Tampere

34655

Research Site, Trinity

35801

Research Site, Huntsville

46825

Research Site, Fort Wayne

50120

Research Site, Toluca

56377

Research Site, Sartell

60220

Research Site, Seinäjoki

68114

Research Site, Omaha

75231

Research Site, Dallas

90404

Research Site, Santa Monica

90813

Research Site, Long Beach

91700

Research Site, Veracruz

92103

Research Site, San Diego

92120

Research Site, San Diego

92404

Research Site, San Bernardino

92653

Research Site, Laguna Hills

92801

Research Site, Anaheim

98104

Research Site, Seattle

98166

Research Site, Burien

98405

Research Site, Tacoma

06762

Research Site, Middlebury

06052

Research Site, New Britain

02914

Research Site, East Providence

T2V 1P9

Research Site, Calgary

V1Y 2H4

Research Site, Kelowna

V3V 1N1

Research Site, Surrey

V5Z 1M9

Research Site, Vancouver

V8T 5G1

Research Site, Victoria

V8V 3N1

Research Site, Victoria

L4M 7G1

Research Site, Barrie

N3R 4N3

Research Site, Brantford

L7N 3V2

Research Site, Burlington

L7S 1V2

Research Site, Burlington

P3E 4T3

Research Site, Greater Sudbury

N1H 5J1

Research Site, Guelph

K7L 3J7

Research Site, Kingston

N2N 2B9

Research Site, Kitchener

N6A 4G5

Research Site, London

L6B 1A1

Research Site, Markham

L3X 1W1

Research Site, Newmarket

P1B 7K8

Research Site, North Bay

M2J 1V1

Research Site, North York

Research Site, Toronto

L6H 3P1

Research Site, Oakville

L1H 7K4

Research Site, Oshawa

M1P 2T7

Research Site, Scarborough Village

M4N 3M5

Research Site, Toronto

M6A 3B5

Research Site, Toronto

J4V 2H3

Research Site, Greenfield Park

H3G 1A4

Research Site, Montreal

07760

Research Site, Mexico City

15-276

Research Site, Bialystok

85-171

Research Site, Bydgoszcz

20-718

Research Site, Lublin

20-954

Research Site, Lublin

45-086

Research Site, Opole

08-110

Research Site, Siedlce

00-416

Research Site, Warsaw

02-781

Research Site, Warsaw

50-088

Research Site, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY